These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 8124207)
1. Efficacy of itraconazole in the prevention of fungal infections among neutropenic patients with hematologic malignancies and intensive chemotherapy. A double blind, placebo controlled study. Vreugdenhil G; Van Dijke BJ; Donnelly JP; Novakova IR; Raemaekers JM; Hoogkamp-Korstanje MA; Koster M; de Pauw BE Leuk Lymphoma; 1993 Nov; 11(5-6):353-8. PubMed ID: 8124207 [TBL] [Abstract][Full Text] [Related]
2. Itraconazole is not effective for the prophylaxis of fungal infections in patients with neutropenia. Kaptan K; Ural AU; Cetin T; Avcu F; Beyan C; Yalçin A J Infect Chemother; 2003 Mar; 9(1):40-5. PubMed ID: 12673406 [TBL] [Abstract][Full Text] [Related]
3. Fluconazole versus itraconazole for the prevention of fungal infections in haemato-oncology. Huijgens PC; Simoons-Smit AM; van Loenen AC; Prooy E; van Tinteren H; Ossenkoppele GJ; Jonkhoff AR J Clin Pathol; 1999 May; 52(5):376-80. PubMed ID: 10560360 [TBL] [Abstract][Full Text] [Related]
4. Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B. Harousseau JL; Dekker AW; Stamatoullas-Bastard A; Fassas A; Linkesch W; Gouveia J; De Bock R; Rovira M; Seifert WF; Joosen H; Peeters M; De Beule K Antimicrob Agents Chemother; 2000 Jul; 44(7):1887-93. PubMed ID: 10858349 [TBL] [Abstract][Full Text] [Related]
5. Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: a randomized, placebo-controlled, double-blind, multicenter trial. GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche dell' Adulto. Menichetti F; Del Favero A; Martino P; Bucaneve G; Micozzi A; Girmenia C; Barbabietola G; Pagańo L; Leoni P; Specchia G; Caiozzo A; Raimondi R; Mandelli F Clin Infect Dis; 1999 Feb; 28(2):250-5. PubMed ID: 10064240 [TBL] [Abstract][Full Text] [Related]
6. Itraconazole versus amphotericin B plus nystatin in the prophylaxis of fungal infections in neutropenic cancer patients. Boogaerts M; Maertens J; van Hoof A; de Bock R; Fillet G; Peetermans M; Selleslag D; Vandercam B; Vandewoude K; Zachée P; De Beule K J Antimicrob Chemother; 2001 Jul; 48(1):97-103. PubMed ID: 11418517 [TBL] [Abstract][Full Text] [Related]
7. An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia. Glasmacher A; Cornely O; Ullmann AJ; Wedding U; Bodenstein H; Wandt H; Boewer C; Pasold R; Wolf HH; Hänel M; Dölken G; Junghanss C; Andreesen R; Bertz H; J Antimicrob Chemother; 2006 Feb; 57(2):317-25. PubMed ID: 16339606 [TBL] [Abstract][Full Text] [Related]
8. Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients. Glasmacher A; Prentice A; Gorschlüter M; Engelhart S; Hahn C; Djulbegovic B; Schmidt-Wolf IG J Clin Oncol; 2003 Dec; 21(24):4615-26. PubMed ID: 14673051 [TBL] [Abstract][Full Text] [Related]
9. Antifungal prophylaxis with itraconazole oral solution in neutropenic patients. Kibbler CC Mycoses; 1999; 42 Suppl 2():121-4. PubMed ID: 10865918 [TBL] [Abstract][Full Text] [Related]
10. A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. U.K. Multicentre Antifungal Prophylaxis Study Group. Morgenstern GR; Prentice AG; Prentice HG; Ropner JE; Schey SA; Warnock DW Br J Haematol; 1999 Jun; 105(4):901-11. PubMed ID: 10554799 [TBL] [Abstract][Full Text] [Related]
11. Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial. Winston DJ; Chandrasekar PH; Lazarus HM; Goodman JL; Silber JL; Horowitz H; Shadduck RK; Rosenfeld CS; Ho WG; Islam MZ; Buell DN Ann Intern Med; 1993 Apr; 118(7):495-503. PubMed ID: 8442620 [TBL] [Abstract][Full Text] [Related]